We report facile one-pot synthesis of water-soluble green fluorescent gold nanoclusters (AuNCs), capped with 8-mercapto-9-propyladenine. The synthesized AuNCs were characterized by Fourier transform infrared (FTIR), powder X-ray diffraction (PXRD), transmission electron microscopy (TEM), 1H NMR, and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. These nanoclusters show high photostability and biocompatibility. We observed that AuNCs stain cell nuclei with high specificity, where the mechanism of AuNC uptake was established through pathway-specific uptake inhibitors. These studies revealed that cell internalization of AuNCs occurs via a macropinocytosis pathway.
Four dinuclear lanthanide complexes [Gd2 (H2L)2 (µ-piv)2 (piv)2]·2CHCl3 (1), [Tb2 (H2L)2 (µ-piv)2 (piv)2]·2CHCl3 (2), [Dy2 (H2L)2 (µ-piv)2 (piv)2]·2CHCl3 (3) and [Eu2 (H2L)2 (µ-piv)2 (piv)2]·2CHCl3 (4) were synthesized by the reaction of appropriate Ln(III) chloride salts and a multidentate ligand, 2,2′-(2-hydroxy-3-methoxy-5-methylbenzylazanediyl)diethanol (H3L) in the presence of pivalic acid. 1–4 are neutral and are held by two monoanionic, [H2L]− ligands. The two lanthanide ions are doubly bridged to each other via two phenolate oxygen atoms. Both the lanthanide ions are nine coordinated and possess a distorted capped square antiprism geometry. Photophysical studies reveal that Tb3+ (2) and Dy3+ (3) complexes display strong ligand-sensitized lanthanide-characteristic emission. The Tb3+ complex (2) shows a very high overall quantum yield of 76.2% with a lifetime of 1.752 ms. Magnetic studies reveal single-molecule magnet behavior for 3 which shows in its ac susceptibility studies a two-step slow relaxation yielding two effective relaxation energy barriers of ΔE = 8.96 K and 35.51 K.
Polymer nanocapsules have attracted a great deal of interest for drug-delivery and bioimaging applications owing to their functional versatility. The present study focuses on the synthesis, characterisation, biocompatibility and genotoxicity studies of polyallylamine hydrochloride (PAH) nanocapsules for drug-delivery studies. In vitro studies included are haemobiocompatibility studies, cytotoxicity and comet assay in peripheral blood mononuclear cells (PBMCs). Post-intravenous administration of PAH nanocapsules, alteration of haematological parameters, inflammatory marker status, toxicity markers in serum and major organs, RT-PCR, western blotting and histopathological studies of major tissues of rats were evaluated for 30 days. The results of these in vitro studies indicated the biocompatible nature of the PAH nanocapsules at the tested concentrations (1.5 × 105 to 6.0 × 105 capsules per mL). The activity of in vivo toxicity markers, inflammatory marker status like cyclooxygenase (COX), lipooxygenase (LOX), nitric oxide synthase (NOS) and prostaglandin E2 (PGE2) activity, alteration of haematological parameters and RT-PCR analysis of important genes like interleukin-1 beta (IL-1β), monocyte chemotactic protein-1(MCP-1), transforming growth factor beta-1 (TGF-β1), kidney injury molecule-1 (Kim-1), heat shock protein gene (Hsp70-1) and tumor necrosis factor alpha (TNF-α) showed the least changes. Western blotting studies on immunoregulatory proteins like cytokines (IL-8), chemokines (MIP-2) and cell-adhesion molecules (VCAM-1 and ICAM-1) showed the smallest levels of toxicity with PAH nanocapsule interaction. Histopathological studies of important tissues showed almost normal architecture after treatment with PAH nanocapsules throughout the experimental period. The abovementioned results confirm the biocompatibility and non-toxicity of PAH nanocapsules, thus suggesting their potential for in vivo drug-delivery and bioimaging applications.